Dingell, Moolenaar Introduce Legislation to Prevent Offshoring Biotech Industry to China
cannot afford to be dependent on foreign competitors – like the People’s Republic of China – for critical pharmaceutical … joint ventures, and equity investments with Chinese covered foreign persons subject to Treasury Department review. Explicitly covers licensing